Multi-Class Combination Drugs |
|
Atripla (efavirenz + tenofovir + emtricitabine) |
Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs) |
(what are they?)
|
Combivir (zidovudine + lamivudine, AZT + 3TC) |
|
Emtriva (emtricitabine, FTC) |
|
Epivir (lamivudine, 3TC) |
|
Epzicom (Kivexa, abacavir + lamivudine, ABC + 3TC) |
|
Retrovir (zidovudine, AZT, ZDV) |
|
Trizivir (abacavir + zidovudine + lamivudine, ABC + AZT + 3TC) |
|
Truvada (tenofovir DF + emtricitabine, TDF + FTC) |
|
Videx & Videx EC (didanosine, ddI) |
|
Viread (tenofovir disoproxil fumarate, TDF) |
|
Zerit (stavudine, d4T) |
|
Ziagen (abacavir, ABC) |
|
Racivir (RCV) |
|
Amdoxovir (AMDX, DAPD) |
|
Apricitabine (SPD754, AVX754) |
|
Elvucitabine (ACH-126,443, Beta-L-Fd4C) |
(what are they?)
|
Immunitin (HE2000, alpha-epibromide) |
|
Proleukin (aldesleukin, Interleukin-2, IL-2) |
|
Remune (HIV-1 Immunogen, Salk vaccine) |
|
BAY 50-4798 |
|
IR103 |
Pharmacokinetic Enhancers |
|
Norvir (ritonavir, RTV) |
|
Cobicistat (GS-9350) |
|
SPI-452 |
Treatments for Opportunistic Infections (OIs)
Treatments for Side Effects
|
|
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) |
(what are they?)
|
Intelence (etravirine, ETV, TMC-125) |
|
Rescriptor (delavirdine, DLV) |
|
Sustiva (Stocrin, efavirenz, EFV) |
|
Viramune (nevirapine, NVP) |
|
Rilpivirine (TMC-278) |
Protease Inhibitors (PIs) |
(what are they?)
|
Agenerase (amprenavir, APV) |
|
Aptivus (tipranavir, TPV) |
|
Crixivan (indinavir, IDV) |
|
Invirase (saquinavir, SQV) |
|
Kaletra (Aluvia, lopinavir/ritonavir, LPV/r) |
|
Lexiva (Telzir, fosamprenavir, FPV) |
|
Norvir (ritonavir, RTV) |
|
Prezista (darunavir, DRV) |
|
Reyataz (atazanavir, ATV) |
|
Viracept (nelfinavir, NFV) |
Entry Inhibitors (including Fusion Inhibitors) |
(what are they?)
|
Fuzeon (enfuvirtide, ENF, T-20) |
|
Selzentry (Celsentri, maraviroc, UK-427,857) |
|
Vicriviroc (SCH-417690, SCH-D) |
|
Ibalizumab (TNX-355) |
|
PRO 140 |
(what are they?)
|
Isentress (raltegravir, MK-0518) |
|
GSK-572 |
|
Elvitegravir (GS-9137) |
|
Bevirimat (PA-457) |
|
Droxia or Hydrea (hydroxyurea, HU) |
|
|
|